|
Hospital descentralizado guillermo rawson (san juan, argentina) reported a potential false negative oxa-48 result on the biofire® blood culture identification 2 (bcid2) panel after testing a patient sample.The customer reported that due to the bcid2 result, the patient experienced a delay in appropriate therapy and unnecessary imaging studies.The customer stated that the patient was not harmed.Biofire has requested further information from the customer and is currently investigating this event.No remedial action, corrective action, preventive action, or field safety corrective action (fsca) has been deemed necessary at this time.
|